ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial-anastrozole is superior to tamoxifen as adjuvant treatment in postmenopausal women with early breast cancer.

被引：0
|
作者：
Bianco, R [1 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
632
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [1] Anastrozole is superior to tamoxifen in the treatment of postmenopausal women with early breast cancer - first results of the ATAC ('Arimidex', Tamoxifen, alone or in combination) trial
    Sainsbury, R
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 137 - 137
  • [2] The ATAC ('Arimidex' Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal (PMI) women
    Tobias, JS
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S92 - S92
  • [3] Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women:: a sub-protocol of the 'Arimidex™ and Tamoxifen Alone or in Combination' (ATAC) trial
    Baum, M
    Dowsett, M
    Coibion, M
    Bianco, AR
    Cuzick, J
    George, WD
    Gray, J
    Howell, A
    Houghton, J
    Williams, N
    Sloane, J
    Tobias, J
    Buzdar, A
    Anderson, MD
    Jackson, I
    Sahmoud, T
    Gallagher, J
    Webster, A
    Gangji, D
    Petrakova, K
    Konopasek, B
    Mares, P
    Vodvarka, P
    Alcazar, A
    Campos, O
    Maxwell, A
    Goedhals
    Hacking, D
    Landers, G
    Smith, L
    Vorobiof, DA
    Werner, ID
    Blamey, R
    Coleman, R
    Grieve, RJ
    Hickish, T
    Howell, A
    Nicholls, JC
    Nicholson, S
    Raymond, S
    Salman, A
    Blum, J
    Clark, R
    Lyss, A
    Miletello, G
    Sternberg, J
    Forbes, J
    Coibion, M
    Nabholtz, JM
    Guastalla, JP
    BRITISH JOURNAL OF CANCER, 2001, 85 (03) : 317 - 324
  • [4] Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the ‘Arimidex™ and Tamoxifen Alone or in Combination’ (ATAC) trial
    British Journal of Cancer, 2001, 85 : 317 - 324
  • [5] Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
    Baum, M
    Buzdar, AU
    Cuzick, J
    Forbes, J
    Houghton, J
    Klijn, JGM
    Sahmoud, T
    LANCET, 2002, 359 (9324): : 2131 - 2139
  • [6] The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal (PM) women.
    Baum, M
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 210 - 210
  • [7] Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial
    Fallowfield, L
    Cella, D
    Cuzick, L
    Francis, S
    Locker, G
    Howell, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (21) : 4261 - 4271
  • [8] Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer - Results of the ATAC (arimidex, tamoxifen alone or in comhination) trial efficacy and safety update analyses
    CANCER, 2003, 98 (09) : 1802 - 1810
  • [9] Quality of Life of Postmenopausal Women in the ATAC (“Arimidex”, Tamoxifen, Alone or in Combination) Trial after Completion of 5 years' Adjuvant Treatment for Early Breast Cancer
    David Cella
    Lesley Fallowfield
    Peter Barker
    Jack Cuzick
    Gershon Locker
    Anthony Howell
    Breast Cancer Research and Treatment, 2006, 100 : 273 - 284
  • [10] Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer
    Cella, David
    Fallowfield, Lesley
    Barker, Peter
    Cuzick, Jack
    Locker, Gershon
    Howell, Anthony
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 (03) : 273 - 284
12345